Emergent BioSolutions' shares rose 95% after announcing Joseph Papa as new President & CEO, replacing Haywood Miller.
Emergent BioSolutions shares rose 95% after announcing Joseph Papa as its new President & CEO, replacing Haywood Miller. Papa, with 35 years of healthcare industry experience, served as CEO & Chairman at Bausch + Lomb. Emergent's shares fell 90% in the last 12 months, prompting the appointment of Papa to drive growth and navigate the company through transformation.
February 21, 2024
4 Articles